Metoprolol is a selective beta-1 blocker commonly employed as the succinate and tartrate derivatives depending if the formulation is designed to be of immediate release or extended release. The possibility of the generation of these formulations comes from the lower systemic bioavailability of the succinate derivative. To this date, it is one of the preferre...
Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension.
Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm.
...
William Beaumont Hospital, Royal Oak, Michigan, United States
Alfred Hospital, Melbourne, Victoria, Australia
Vestre Viken Hospital Trust, Baerum Hospital, Rud, Akershus, Norway
Parkland Memorial Hospital, Dallas, Texas, United States
Martini Hospital, Groningen, Netherlands
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Royal Melbourne Hospital, Melbourne, Victoria, Australia
Vanderbilt University, Nashville, Tennessee, United States
CRC, Med. Klinik 4, University of Erlangen-Nürnberg, Erlangen, Germany
St. Paul Heart Clinic, St. Paul, Minnesota, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.